EP1094012B1 - Plastic closure for vials and other medical containers - Google Patents
Plastic closure for vials and other medical containers Download PDFInfo
- Publication number
- EP1094012B1 EP1094012B1 EP00121655A EP00121655A EP1094012B1 EP 1094012 B1 EP1094012 B1 EP 1094012B1 EP 00121655 A EP00121655 A EP 00121655A EP 00121655 A EP00121655 A EP 00121655A EP 1094012 B1 EP1094012 B1 EP 1094012B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- closure
- container
- plastic closure
- polymer
- plastic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
Definitions
- This invention relates to an improved plastic closure such as a cap or collar for closing or sealing containers such as vials containing a medicament which eliminates the problems associated with a malleable metal cap or collar such as aluminum.
- the plastic closure of this invention may be used as a cap to seal a conventional vial having an elastomeric stopper or as a collar for retaining a fluid transferset separate from or integral with the collar.
- Such substances may be in a dry or powdered form to increase shelf life and reduce inventory space.
- Such dry or powdered substances are generally stored in a sealed vial and later reconstituted in liquid form for administration to a patient by adding a diluent or solvent.
- the substance may be in liquid or even gaseous form.
- a conventional vial for storing a pharmaceutical substance generally includes an open end, a radial rim portion surrounding the open end and a reduced diameter neck portion adjacent the rim portion.
- the vial is conventionally sealed with an elastomeric stopper which generally includes a tubular portion inserted into the neck of the vial and a planar rim portion which overlies the vial rim.
- the stopper is normally secured to the vial with a thin malleable metal cap, such as aluminum.
- the aluminum cap includes a tubular portion which surrounds the rim portions of the stopper and vial, an inwardly projecting annular portion which overlies the rim portion of the stopper and a distal end portion which is crimped or deformed radially into the vial neck beneath the vial rim portion. Because aluminum is malleable, the collar accommodates the buildup of tolerances of the dimensions of the stopper and vial rim.
- the dimensions and tolerances of standard vials and stoppers are set by the International Standards Organization (ISO).
- the radial portion of the aluminum cap which overlies the stopper rim portion may be closed, in which case the aluminum cap is removed by "peeling" the aluminum cap from the vial.
- a pre-slit tab located in the middle area is provided which overlies the vial rim, permitting the cap to be torn from the top and peeled from the vial prior to use.
- This closed embodiment of an aluminum cap has several disadvantages. First, the tearing of the metal cap creates sharp edges which may cut or damage sterile gloves and cut the person administering the drug, thereby exposing both the healthcare worker and the patient to disease and contamination of the drug. Second, the tearing of the aluminum cap generates metal particles which may also contaminate the drug.
- the aluminum collar includes a central opening and a shallow plastic cup-shaped cap is received over the aluminum collar having a central projecting riveting portion which is received and secured in the central opening of the aluminum collar.
- the plastic cap is then removed by forcing the flip-off cap away from the aluminum collar, which tears an annular serrated portion surrounding the central opening and exposes an opening in the collar for receipt of a hypodermic needle or the like.
- This embodiment reduces but does not eliminate the possibility of tearing the sterile gloves of the healthcare worker. More importantly, however, aluminum dust is still created which may contaminate the medicament.
- Aluminum collars have also been used to secure a fluid transferset on vials. Transfersets may be utilized, for example, to transfer fluid from a syringe to a vial, such as to reconstitute a dry or powdered substance in a vial by adding a diluent or solvent. The reconstituted substance may then be withdrawn from the vial by the syringe.
- the inner surface of the transferset may be part of the fluid path and the aluminum collar or ring may bring aluminum particles in the sterile room where the substance is added to the vial or into the fluid path contaminating the substance.
- the prior art also includes snap-on cup-shaped plastic caps or collars having a radially inwardly projecting end portion which is snapped over the rim portion of the vial. Snap-on plastic collars, however, do not assure adequate sealing of the vial or fully accommodate the tolerances of standard vials and stoppers as required.
- a plastic closure for sealing a container corresponding to the first part of claim 1 is disclosed in FR-A-1328635.
- the plastic closure comprises an end wall and a skirt depending therefrom. When the closure has been positioned on the neck of a container, the skirt is deformed by L-shaped tongues, so that the closure is anchored on the container.
- the plastic closure of this invention solving these problems and permitting the use of the plastic closure of this invention for attaching and sealing containers is defined by claim 1.
- the polymer has an elongation at yield between 5% and 10%, an elongation at break greater than 100% and a flexural modulus of greater than 1,900MPa.
- the plastic closure for sealing a cartridge or other medical container of this invention eliminates the problems associated with a malleable metal or aluminum cap or collar, but accommodates the buildup of tolerances of the rim portion of the container and the elastomeric stopper, when used.
- the plastic closure of this invention is relatively inexpensive to manufacture and use.
- the plastic closure of this invention may be utilized as a cap to seal a conventional pharmaceutical cartridge.
- the term closure is generic to either a cap or collar.
- the plastic closure for sealing a container of this invention may be utilized with any number of conventional cartridges having an open end and a reduced diameter neck portion adjacent the open end.
- the plastic closure of this invention includes a generally tubular portion and a portion which is deformed radially or crimped toward the reduced diameter portion of the container to retain the closure on the container and as a cap to seal the open end of the container.
- the plastic closure of this invention may also be used as a cap or collar with a conventional vial and elastomeric stopper.
- the plastic closure of this invention is formed of a polymer which is sufficiently malleable to permit radial deformation, yet sufficiently rigid to retain its shape following deformation and sufficiently resistant to creep to maintain the seal between the plastic cap and the container following radial deformation.
- the preferred embodiment of the plastic closure of this invention is formed of a composite polymer including a polymer alloy or melt blend which includes a relatively tough soft malleable co-polymer and a relatively rigid polymer.
- the composite polymer is a polymer alloy of a relatively soft malleable co-polymer and a relatively rigid polymer.
- the preferred relatively rigid polymer is a polyamide or a polycarbonate and the preferred relatively soft co-polymer may be selected from polyesters or polyolefins.
- the resultant polymer alloy or composite preferably has an elongation at yield between 5% and 10% and an elongation at break greater than 100% with a flectural modulus of greater than 1900 MPa.
- the plastic closure of this invention includes a generally cylindrical tubular portion preferably having an internal diameter generally equal to or slightly greater than the external diameter of the rim portion of the container adapted to be received over the rim portion of the container having a free distal end adapted to be deformed radially inwardly or crimped beneath the rim portion of the container and sealed relation.
- the plastic cap or collar of this invention may also include a radially inwardly projecting proximate portion which overlies the rim portion of the container and/or the stopper.
- This radial portion may be closed or more preferably includes a central opening which may be closed with a flip-off or peel-off type plastic closure or seal.
- the peel-off seal includes a looped end portion which is welded or glued in place to provide an indication of tampering and a free end which may be gripped to remove the seal.
- the method of this invention includes forming a plastic closure having a generally cylindrical tubular portion having an internal diameter generally equal to or slightly greater than an outside diameter of the rim portion of the container and an integral radial rim portion, disposing the closure over the rim of the container with the radial rim portion overlying the rim portion of the vial and the tubular portion surrounding the container rim, and then radially permanently deforming or crimping the free end of the tubular portion of the collar toward the neck portion of the container, beneath the rim portion, permanently securing the closure on the container and sealing the container open end.
- the plastic closure of this invention is formed by injection molding the plastic closure from a polymeric alloy or a composite having a relatively soft malleable polymer or co-polymer and a relatively rigid polymer, wherein a polymeric alloy or composite is formed during the injection molding.
- a resilient or polymeric ring is utilized to prevent rotation of the closure on the container, the ring may be co-injected with the polymer forming the closure or an annular groove may be formed in the tubular portion of the closure, adjacent the free end.
- the method then includes inserting the annular resilient ring in the groove prior to radial permanent deformation of the free end of the closure as described, such that the resilient ring is biased against the rim portion of the container.
- a thermoplastic elastomer may also be co-injected with the polymer forming the closure to form a coating or film on the inside surface of the closure which is integrally bonded to the polymer of the cap.
- the plastic closure of this invention may be utilized with a cartridge or other medical container having a conventional elastomeric stopper or as a collar in combination with a transferset having a sealing member as disclosed in the prior art or more preferably the collar portion may be formed integral with components of the transferset.
- the plastic closure of this invention is used to seal a container having an elastomeric stopper, the proximate radial lip of the closure is received over and preferably biased against the resilient radial lip of the stopper during radial deformation or crimping of the free of the tubular portion of the closure beneath the rim of the container.
- the plastic closure of this invention thus eliminates the problems associated with malleable metal collars or caps, such as aluminum, and is relatively inexpensive, and simple to manufacture, particularly when compared with aluminum caps having a protective coating.
- the plastic closure of this invention assures an excellent seal of the container and can be injection molded in a clean environment or washed, if necessary.
- the plastic closure of this invention accommodates the tolerances of the vial and particularly the buildup of tolerance variations in the combination of a conventional vial and elastomeric stopper.
- FIGs 1 to 3 illustrate one preferred embodiment of a pharmaceutical substance container, stopper and cap assembly 20 of this invention.
- the closure of this invention may be utilized to seal various containers and is particularly useful for sealing containers for holding pharmaceuticals such as the conventional vial 22 illustrated in Figures 1 to 3 and the cartridges shown in Figures 4 through 8.
- the vial includes an open end 24, an annular radially extending rim portion 26 and a neck portion 28 adjacent the rim portion.
- the neck portion 28 of the vial has a reduced diameter when compared to the rim portion 26 and the container portion 30.
- the internal surface 31 of the vial adjacent the open end 24 is generally cylindrical.
- Medicament vials of this type are generally formed of glass or a sterilizable plastic.
- the open end 24 of the vial is typically closed with an elastomeric stopper 32 having a tubular body portion 34 which is received in the open end 24 of the vial and a planar rim portion 36 which overlies the rim portion 26 of the vial as shown in Figure 1.
- the stopper is generally formed of a resilient elastomeric material such as synthetic or natural rubber.
- the central portion 38 of the planar rim portion 36 may be pierced with a hypodermic needle, for example, to either withdraw fluid from the vial or add a solvent or diluent to the vial where the substance in the vial is in dry or powder form.
- the tubular portion 34 of the stopper has an external diameter generally greater than the internal diameter of the internal cylindrical surface 31 of the vial to provide a tight or interference fit.
- FIG. 1 One preferred embodiment of the closure 40 is shown in Figure 1 attached to a vial 22 and stopper 32 assembly, prior to assembly in Figure 2 and during assembly in Figure 3.
- This embodiment of the collar 40 includes a tubular portion 42 which surrounds the rim portion 26 of the vial and the planar rim portion 36 of the stopper. Where the external surface of the rim portion 26 of the vial is cylindrical, the tubular portion 42 of the collar will generally also be cylindrical. As shown in Figure 1, the free end 44 of the tubular portion 42 is deformed inwardly or crimped beneath the adjacent surface of the rim portion 26 of the vial, permanently securing the collar 40 on the vial and sealing the vial.
- This embodiment of the collar 40 also includes an integral radial proximate portion 46 which overlies the rim portions 26 and 36 of the vial and stopper, respectively.
- the radial portion 46 is preferably integral with the tubular portion 42 of the collar.
- This embodiment of the collar 40 also includes a central opening 48 which overlies the central portion 38 of the stopper, preferably coaxially aligned with the central portion of the stopper. As described below, however, the central opening 48 may be eliminated in certain applications of this invention.
- proximate and distal are used solely for ease of description, wherein the term proximate refers to elements or portions of elements closest to the rim portion 36 of the stopper and distal refers to elements or portions of elements more remote from the rim portion of the stopper. Further, the terms cap and collar are sometimes used herein interchangeably.
- the illustrated collar 40 includes a shallow cup-shaped cap 50.
- the cap 50 includes a tubular portion 52 which surrounds the proximate portion of the tubular portion 42 of the collar, an integral central radial bridging portion 54 and a plurality of U-shaped tabs which, in the disclosed embodiment, are integral with the central bridging portion 54.
- the U-shaped tabs 56 are received through the central opening 48 of the collar and snap in place to securely retain the cap 50 on the collar 40.
- the cap 50 may be preassembled on the collar 40 prior to assembly of the collar on the vial.
- the tabs 56 may also be separate members or the central portion of the cap 50 including the tabs 56 may be a separate member.
- the collar 40 is then assembled on the vial 22 as shown in Figure 2.
- the tubular portion 34 of the stopper is first inserted into the opening 24 of the vial 22 generally after the vial is filled.
- the plastic collar 40 of this invention may be used with various containers including conventional medicament vials as shown.
- the vial 22 will first be filled with a medicament.
- the tubular portion 42 of the collar 40 is then received over the rim portion 36 of the stopper and the rim portion 26 of the vial as shown in Figure 3.
- the free end 44 (shown before deformation in phantom in Figure 3) is then deformed radially beneath the radial rim 26 of the vial by a suitable tool, such as the crimping tool 58 shown in Figure 3.
- the disclosed embodiment of the crimping tool includes a conical rim 60 which deforms or crimps the free end 44 of the collar beneath the rim 26 of the vial.
- the tool 58 is rotated around the rim 26 of the collar 40, deforming or crimping the free end 44 as shown in Figures 1 and 3.
- the sealed vial may now be stored for later use.
- the cap 50 When the vial is ready for use, the cap 50 may be removed simply by forcing one side of the cap 50 upwardly away from the collar 40, removing the cap 50 from the collar 40 and exposing the central opening 48 of the collar and the central portion 38 of the stopper. The central portion 38 of the stopper may then be pierced with a conventional hypodermic needle, for example, providing access to the container portion 30 of the vial.
- a conventional hypodermic needle for example, providing access to the container portion 30 of the vial.
- the material of the cap 50 is selected to provide resiliency, such as polyethylene or polypropylene
- the tabs 56 will bend under thumb pressure, permitting easy removal of the closure 50.
- the material of the cap is relatively rigid, at least some of the tabs 56 will break also permitting removal of the cap.
- the radial portion 46 of the collar is preferably compressed against the resilient rim portion 32 of the elastomeric stopper during radial deformation of the free end 44 of the collar to assure a secure seal of the vial following installation.
- the tabs 56 are thus compressed into the radial rim 32 of the stopper as shown in Figure 1.
- the polymer selected for the plastic closure of this invention can best be described by its required physical properties.
- the polymer must be sufficiently malleable to permit radial deformation or crimping, yet sufficiently rigid to retain its shape following deformation.
- the polymer must also be sufficiently resistant to creep to maintain the seal between the plastic cap and the container following radial deformation. It has been found that a polymer having an elongation at yield between 5% and 10% and an elongation at break greater than 100%, combined with a flexural modulus of greater than 1,900 MPa has superior performance.
- the polymer should also be sterilizable and, in certain applications such as the plastic collar for a vial transferset described below, the polymer is preferably relatively clear and maintains its clarity under the stress of deformation or crimping. It has been found that certain polymer alloys or composite polymers including melt blends or alloys and co-polymers having polymers of different malleability and rigidity are preferred in many applications. That is, the plastic closure of this invention is preferably formed of a polymer alloy, composite polymer or co-polymer including a relatively rigid polymer and a tough relatively soft malleable co-polymer.
- the most preferred polymer is a polymer alloy or melt blend including a polyamide or polycarbonate as the rigid polymer providing the strength and resistance to creep desired for this application.
- the relatively soft malleable co-polymer may be selected from various polymers including polyesters and polyolefins; however, a polymer alloy including a polycarbonate or polyamide and a polyester has been found particularly suitable for this application.
- plastic collar of this invention is not limited to a specific polymer, provided the polymer has the desired physical properties described above.
- Suitable polymers for the plastic collar of this invention include EASTAR ® MB polymers, which are melt blend and alloy polymers and EASTAR ® thermoplastic polymers, which are neat polymers sold by Eastman Chemical Company of Kingsport, Tennessee and Eastman Chemical AG of Switzerland under the trade names "DA003, DN003" and "DN004". These materials are polymer melt blends, alloys and co-polymers of polycarbonate or polyamide and polyester.
- melt blends and alloys refer to polymeric compositions having two or more polymers of different physical properties or characteristics, such as the EASTAR ® polymers of Eastman Chemical Company described above which include a polycarbonate or polyamide and a polyester.
- the polymer selected for the plastic collar of this invention may also include fillers and other constituents which would be more accurately described as a composite.
- the base polymers may still be a polymeric melt blend or alloy.
- composite is used in its broadest sense to include alloys or melt blends, composites and co-polymers. As will be understood, the manufacturer or supplier of the raw material will normally blend the polymers based upon the specifications of the customer.
- the polymers may be co-injected to form a polymeric melt blend, alloy or composite or formed by any other suitable processes. It is anticipated, however, that other polymers having the described physical characteristics may also be utilized in the plastic collar or cap of this invention. In certain applications, it may also be desirable to coat at least the interior surface 43 of the collar shown in Figure 2 with a thermoplastic elastomer, or the entire collar may have a thin layer of a thermoplastic elastomer. The thermoplastic elastomer coating may be applied as a film or by co-injection with the polymer forming the collar 40. The collar 40 and the closure 50 may be formed by conventional injection molding processes.
- FIGS 1-3 include an illustration of a generic vial or container for a pharmaceutical substance
- this invention is particularly useful for closing off or sealing cartridges that are prefilled with pharmaceutical substances.
- Such cartridges are well-known and typically are used with injector devices where the cartridge is inserted into the appropriate portion of the injector device by a medical professional prior to administering an injection.
- the cartridges typically are prefilled with the desired pharmaceutical substance.
- a variety of cartridge designs are utilized to accommodate substances in different forms.
- FIGS 4 and 5 illustrate one example cartridge that includes a plastic closure 140 designed according to this invention.
- the cartridge 122 is utilized within an injector device that is schematically illustrated at 180.
- the cartridge 122 includes an open end 124 that is closed off by an elastomeric stopper member 132 in cooperation with the plastic closure 140.
- a stopper member 170 operates to maintain a substance within the interior 131 of the cartridge 122.
- the stopper member 170 also cooperates with the injector mechanisms schematically illustrated at 160 of the injector 180 in a conventional manner.
- the elastomeric stopper member 132 extends across the opening 124 and includes a portion 136 that rests against the rim portion 126 of the cartridge 122.
- a central portion 138 of the stopper member 132 extends across the opening 124 and is piercable by a hypodermic needle device, for example, so that a pharmaceutical substance within the cartridge 122 can be injected in a desired manner.
- the cap 140 has a portion 144 that is crimped or radially deformed inwardly toward the reduced neck portion 128 of the cartridge 122.
- the radial portion 146 of the cap 140 effectively maintains the stopper member 132 in place against the end of the shoulder portion 126 of the cartridge 122.
- Figures 6 and 7 illustrate another example embodiment where a plastic closure designed according to this invention is provided on the end of a cartridge 222.
- the cartridge 222 includes two stopper members 270 and 272.
- a first substance 276 is maintained between the stoppers 270 and 272 when the cartridge 222 is prefilled by a pharmaceutical supplier, for example.
- a second substance 278 is maintained between the stopper 272 and the stopper member 232 at the open end of the cartridge 222.
- a bypass passage 274 is provided so that when an injector mechanism is used and a stopper member 270 is moved toward the end of the cartridge 222 including the stopper member 232, the stopper member 272 proceeds in the same direction and the substance or fluid 276 is permitted to flow through the bypass 274 to mix with the substance 278.
- this type of cartridge is a especially useful for prefilling cartridges with pharmaceutical substances that are maintained in a dry, powdered or lyophilized form.
- the substance 276 is typically used for reconstituting the substance 278 prior to injecting that substance into a patient.
- the cap 240 includes the tubular collar portion 242 and the radially crimped or deformed portion 244 that both at least partially engage the shoulder portion 226 at the end of the cartridge 222.
- the stopper member 232 in this embodiment includes a central portion 238 and an additional flange portion near the end 236 for engaging the end of the cartridge 222. Otherwise, the operation of the example of Figures 6 and 7 is the same as described above.
- Figure 8 illustrates another embodiment where a plastic cap 340 designed according to this invention is used to close off the end of a cartridge 322.
- the cartridge 322 includes a stopper member 338 at the open end 324 and a stopper or plunger member 370 at the opposite end.
- a chamber separating portion 384 operates to maintain substances within the chambers 380 and 382 separate from each other until a desired sequence of injection or a desired mixing operation needs to be completed.
- the operation of a multi-chamber cartridge such as that illustrated in Figure 8 is known in the art.
- the inclusion of a plastic cap 340 designed according to this invention provides additional advantages compared to the use of conventional aluminum caps as described above.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Closures For Containers (AREA)
Abstract
Description
- This invention relates to an improved plastic closure such as a cap or collar for closing or sealing containers such as vials containing a medicament which eliminates the problems associated with a malleable metal cap or collar such as aluminum. The plastic closure of this invention may be used as a cap to seal a conventional vial having an elastomeric stopper or as a collar for retaining a fluid transferset separate from or integral with the collar.
- It is conventional to store pharmaceutical such as drugs substances or vaccines in a sealed vial or other container for later use. Such substances may be in a dry or powdered form to increase shelf life and reduce inventory space. Such dry or powdered substances are generally stored in a sealed vial and later reconstituted in liquid form for administration to a patient by adding a diluent or solvent. Alternatively, the substance may be in liquid or even gaseous form.
- A conventional vial for storing a pharmaceutical substance generally includes an open end, a radial rim portion surrounding the open end and a reduced diameter neck portion adjacent the rim portion. The vial is conventionally sealed with an elastomeric stopper which generally includes a tubular portion inserted into the neck of the vial and a planar rim portion which overlies the vial rim. The stopper is normally secured to the vial with a thin malleable metal cap, such as aluminum. The aluminum cap includes a tubular portion which surrounds the rim portions of the stopper and vial, an inwardly projecting annular portion which overlies the rim portion of the stopper and a distal end portion which is crimped or deformed radially into the vial neck beneath the vial rim portion. Because aluminum is malleable, the collar accommodates the buildup of tolerances of the dimensions of the stopper and vial rim. The dimensions and tolerances of standard vials and stoppers are set by the International Standards Organization (ISO).
- The radial portion of the aluminum cap which overlies the stopper rim portion may be closed, in which case the aluminum cap is removed by "peeling" the aluminum cap from the vial. A pre-slit tab located in the middle area is provided which overlies the vial rim, permitting the cap to be torn from the top and peeled from the vial prior to use. This closed embodiment of an aluminum cap has several disadvantages. First, the tearing of the metal cap creates sharp edges which may cut or damage sterile gloves and cut the person administering the drug, thereby exposing both the healthcare worker and the patient to disease and contamination of the drug. Second, the tearing of the aluminum cap generates metal particles which may also contaminate the drug. The dangers associated with the tearing of an aluminum cap has been solved in part by adding a "flip-off" plastic cap. In one such embodiment, the aluminum collar includes a central opening and a shallow plastic cup-shaped cap is received over the aluminum collar having a central projecting riveting portion which is received and secured in the central opening of the aluminum collar. The plastic cap is then removed by forcing the flip-off cap away from the aluminum collar, which tears an annular serrated portion surrounding the central opening and exposes an opening in the collar for receipt of a hypodermic needle or the like. This embodiment reduces but does not eliminate the possibility of tearing the sterile gloves of the healthcare worker. More importantly, however, aluminum dust is still created which may contaminate the medicament. It is also important to note that metallic dust is also created simply by forming and affixing the aluminum collar to the vial because aluminum dust is created in forming the aluminum collar, crimping of the collar and removal of the flip-off plastic cap. Aluminum collars have also been used to secure a fluid transferset on vials. Transfersets may be utilized, for example, to transfer fluid from a syringe to a vial, such as to reconstitute a dry or powdered substance in a vial by adding a diluent or solvent. The reconstituted substance may then be withdrawn from the vial by the syringe. The inner surface of the transferset may be part of the fluid path and the aluminum collar or ring may bring aluminum particles in the sterile room where the substance is added to the vial or into the fluid path contaminating the substance. There have been attempts to reduce this problem by applying a coating to the aluminum cap or collar. Finally, the prior art also includes snap-on cup-shaped plastic caps or collars having a radially inwardly projecting end portion which is snapped over the rim portion of the vial. Snap-on plastic collars, however, do not assure adequate sealing of the vial or fully accommodate the tolerances of standard vials and stoppers as required.
- A plastic closure for sealing a container corresponding to the first part of claim 1 is disclosed in FR-A-1328635. The plastic closure comprises an end wall and a skirt depending therefrom. When the closure has been positioned on the neck of a container, the skirt is deformed by L-shaped tongues, so that the closure is anchored on the container.
- It is an object of the invention to provide a closure for vials and other medical containers which may be utilized with conventional containers, such as pharmaceutical vials or cartridges, which assures sealing of the container and which achieves a good level of cleanliness, without metal particles or dust which may contaminate the contents, and which does not expose the healthcare worker to sharp metal edges.
- The plastic closure of this invention solving these problems and permitting the use of the plastic closure of this invention for attaching and sealing containers is defined by claim 1. According to the invention, the polymer has an elongation at yield between 5% and 10%, an elongation at break greater than 100% and a flexural modulus of greater than 1,900MPa.
- The plastic closure for sealing a cartridge or other medical container of this invention eliminates the problems associated with a malleable metal or aluminum cap or collar, but accommodates the buildup of tolerances of the rim portion of the container and the elastomeric stopper, when used. The plastic closure of this invention is relatively inexpensive to manufacture and use. The plastic closure of this invention may be utilized as a cap to seal a conventional pharmaceutical cartridge. As used herein, the term closure is generic to either a cap or collar.
- The plastic closure for sealing a container of this invention may be utilized with any number of conventional cartridges having an open end and a reduced diameter neck portion adjacent the open end. The plastic closure of this invention includes a generally tubular portion and a portion which is deformed radially or crimped toward the reduced diameter portion of the container to retain the closure on the container and as a cap to seal the open end of the container. The plastic closure of this invention may also be used as a cap or collar with a conventional vial and elastomeric stopper. In the preferred embodiment, the plastic closure of this invention is formed of a polymer which is sufficiently malleable to permit radial deformation, yet sufficiently rigid to retain its shape following deformation and sufficiently resistant to creep to maintain the seal between the plastic cap and the container following radial deformation.
- The preferred embodiment of the plastic closure of this invention is formed of a composite polymer including a polymer alloy or melt blend which includes a relatively tough soft malleable co-polymer and a relatively rigid polymer. In the most preferred embodiment of the plastic closure of this invention, the composite polymer is a polymer alloy of a relatively soft malleable co-polymer and a relatively rigid polymer. The preferred relatively rigid polymer is a polyamide or a polycarbonate and the preferred relatively soft co-polymer may be selected from polyesters or polyolefins. The resultant polymer alloy or composite preferably has an elongation at yield between 5% and 10% and an elongation at break greater than 100% with a flectural modulus of greater than 1900 MPa.
- Where the container or cartridge includes a radial rim portion adjacent the open end, the plastic closure of this invention includes a generally cylindrical tubular portion preferably having an internal diameter generally equal to or slightly greater than the external diameter of the rim portion of the container adapted to be received over the rim portion of the container having a free distal end adapted to be deformed radially inwardly or crimped beneath the rim portion of the container and sealed relation. The plastic cap or collar of this invention may also include a radially inwardly projecting proximate portion which overlies the rim portion of the container and/or the stopper. This radial portion may be closed or more preferably includes a central opening which may be closed with a flip-off or peel-off type plastic closure or seal. In the preferred embodiment, the peel-off seal includes a looped end portion which is welded or glued in place to provide an indication of tampering and a free end which may be gripped to remove the seal.
- The method of this invention includes forming a plastic closure having a generally cylindrical tubular portion having an internal diameter generally equal to or slightly greater than an outside diameter of the rim portion of the container and an integral radial rim portion, disposing the closure over the rim of the container with the radial rim portion overlying the rim portion of the vial and the tubular portion surrounding the container rim, and then radially permanently deforming or crimping the free end of the tubular portion of the collar toward the neck portion of the container, beneath the rim portion, permanently securing the closure on the container and sealing the container open end. In the most preferred embodiment of the method of this invention, the plastic closure of this invention is formed by injection molding the plastic closure from a polymeric alloy or a composite having a relatively soft malleable polymer or co-polymer and a relatively rigid polymer, wherein a polymeric alloy or composite is formed during the injection molding. Where a resilient or polymeric ring is utilized to prevent rotation of the closure on the container, the ring may be co-injected with the polymer forming the closure or an annular groove may be formed in the tubular portion of the closure, adjacent the free end. The method then includes inserting the annular resilient ring in the groove prior to radial permanent deformation of the free end of the closure as described, such that the resilient ring is biased against the rim portion of the container. A thermoplastic elastomer may also be co-injected with the polymer forming the closure to form a coating or film on the inside surface of the closure which is integrally bonded to the polymer of the cap.
- The plastic closure of this invention may be utilized with a cartridge or other medical container having a conventional elastomeric stopper or as a collar in combination with a transferset having a sealing member as disclosed in the prior art or more preferably the collar portion may be formed integral with components of the transferset. Where the plastic closure of this invention is used to seal a container having an elastomeric stopper, the proximate radial lip of the closure is received over and preferably biased against the resilient radial lip of the stopper during radial deformation or crimping of the free of the tubular portion of the closure beneath the rim of the container. The plastic closure of this invention thus eliminates the problems associated with malleable metal collars or caps, such as aluminum, and is relatively inexpensive, and simple to manufacture, particularly when compared with aluminum caps having a protective coating. The plastic closure of this invention assures an excellent seal of the container and can be injection molded in a clean environment or washed, if necessary. Finally, the plastic closure of this invention accommodates the tolerances of the vial and particularly the buildup of tolerance variations in the combination of a conventional vial and elastomeric stopper. Other advantages and meritorious features of the present invention will be more fully understood from the following description of the preferred embodiments, the appended claims and the drawings, a brief description of which follows.
-
- Figure 1 is a side cross-sectional view of one preferred embodiment of the plastic closure of this invention secured to and sealing a conventional vial having an elastomeric stopper;
- Figure 2 is an exploded side cross-sectional view of the open end of a conventional vial, elastomeric stopper and the plastic closure shown in Figure 1 prior to radial deformation of the free end of the closure;
- Figure 3 is a side partially cross-sectioned view of the assembly shown in Figure 1 illustrating radial deformation or crimping of the closure;
- Figure 4 is a cross sectional view of a plastic closure of this invention assembled on a cartridge used in an injector device;
- Figure 5 is a close up view of selected portions of Figure 4;
- Figure 6 is a cross-sectional view of a another example cartridge having the plastic collar of this invention;
- Figure 7 is a close up view of selected portions of Figure 6;
- Figure 8 is a cross-sectional view of another example cartridge having closure designed according to this invention;
- Figures 1 to 3 illustrate one preferred embodiment of a pharmaceutical substance container, stopper and
cap assembly 20 of this invention. As set forth above, the closure of this invention may be utilized to seal various containers and is particularly useful for sealing containers for holding pharmaceuticals such as theconventional vial 22 illustrated in Figures 1 to 3 and the cartridges shown in Figures 4 through 8. The vial includes anopen end 24, an annular radially extendingrim portion 26 and aneck portion 28 adjacent the rim portion. Theneck portion 28 of the vial has a reduced diameter when compared to therim portion 26 and the container portion 30. Theinternal surface 31 of the vial adjacent theopen end 24 is generally cylindrical. Medicament vials of this type are generally formed of glass or a sterilizable plastic. Theopen end 24 of the vial is typically closed with anelastomeric stopper 32 having atubular body portion 34 which is received in theopen end 24 of the vial and aplanar rim portion 36 which overlies therim portion 26 of the vial as shown in Figure 1. The stopper is generally formed of a resilient elastomeric material such as synthetic or natural rubber. Thecentral portion 38 of theplanar rim portion 36 may be pierced with a hypodermic needle, for example, to either withdraw fluid from the vial or add a solvent or diluent to the vial where the substance in the vial is in dry or powder form. Thetubular portion 34 of the stopper has an external diameter generally greater than the internal diameter of the internalcylindrical surface 31 of the vial to provide a tight or interference fit. - One preferred embodiment of the
closure 40 is shown in Figure 1 attached to avial 22 andstopper 32 assembly, prior to assembly in Figure 2 and during assembly in Figure 3. This embodiment of thecollar 40 includes atubular portion 42 which surrounds therim portion 26 of the vial and theplanar rim portion 36 of the stopper. Where the external surface of therim portion 26 of the vial is cylindrical, thetubular portion 42 of the collar will generally also be cylindrical. As shown in Figure 1, thefree end 44 of thetubular portion 42 is deformed inwardly or crimped beneath the adjacent surface of therim portion 26 of the vial, permanently securing thecollar 40 on the vial and sealing the vial. This embodiment of thecollar 40 also includes an integral radialproximate portion 46 which overlies therim portions radial portion 46 is preferably integral with thetubular portion 42 of the collar. This embodiment of thecollar 40 also includes acentral opening 48 which overlies thecentral portion 38 of the stopper, preferably coaxially aligned with the central portion of the stopper. As described below, however, thecentral opening 48 may be eliminated in certain applications of this invention. As used herein, the terms proximate and distal are used solely for ease of description, wherein the term proximate refers to elements or portions of elements closest to therim portion 36 of the stopper and distal refers to elements or portions of elements more remote from the rim portion of the stopper. Further, the terms cap and collar are sometimes used herein interchangeably. - The illustrated
collar 40 includes a shallow cup-shapedcap 50. In the disclosed embodiment, thecap 50 includes atubular portion 52 which surrounds the proximate portion of thetubular portion 42 of the collar, an integral centralradial bridging portion 54 and a plurality of U-shaped tabs which, in the disclosed embodiment, are integral with thecentral bridging portion 54. TheU-shaped tabs 56 are received through thecentral opening 48 of the collar and snap in place to securely retain thecap 50 on thecollar 40. As shown in Figure 2, thecap 50 may be preassembled on thecollar 40 prior to assembly of the collar on the vial. Thetabs 56 may also be separate members or the central portion of thecap 50 including thetabs 56 may be a separate member. - The
collar 40 is then assembled on thevial 22 as shown in Figure 2. In a typical application, thetubular portion 34 of the stopper is first inserted into theopening 24 of thevial 22 generally after the vial is filled. As set forth above, theplastic collar 40 of this invention may be used with various containers including conventional medicament vials as shown. Thus, in a typical application, thevial 22 will first be filled with a medicament. Thetubular portion 42 of thecollar 40 is then received over therim portion 36 of the stopper and therim portion 26 of the vial as shown in Figure 3. The free end 44 (shown before deformation in phantom in Figure 3) is then deformed radially beneath theradial rim 26 of the vial by a suitable tool, such as the crimpingtool 58 shown in Figure 3. The disclosed embodiment of the crimping tool includes aconical rim 60 which deforms or crimps thefree end 44 of the collar beneath therim 26 of the vial. In a typical application, thetool 58 is rotated around therim 26 of thecollar 40, deforming or crimping thefree end 44 as shown in Figures 1 and 3. In certain applications, it may be desirable to heat either thefree end 44 of the collar or thetool 58 to facilitate crimping. The sealed vial may now be stored for later use. - When the vial is ready for use, the
cap 50 may be removed simply by forcing one side of thecap 50 upwardly away from thecollar 40, removing thecap 50 from thecollar 40 and exposing thecentral opening 48 of the collar and thecentral portion 38 of the stopper. Thecentral portion 38 of the stopper may then be pierced with a conventional hypodermic needle, for example, providing access to the container portion 30 of the vial. Where the material of thecap 50 is selected to provide resiliency, such as polyethylene or polypropylene, thetabs 56 will bend under thumb pressure, permitting easy removal of theclosure 50. Alternatively, where the material of the cap is relatively rigid, at least some of thetabs 56 will break also permitting removal of the cap. It should also be noted that theradial portion 46 of the collar is preferably compressed against theresilient rim portion 32 of the elastomeric stopper during radial deformation of thefree end 44 of the collar to assure a secure seal of the vial following installation. Thetabs 56 are thus compressed into theradial rim 32 of the stopper as shown in Figure 1. - The polymer selected for the plastic closure of this invention can best be described by its required physical properties. The polymer must be sufficiently malleable to permit radial deformation or crimping, yet sufficiently rigid to retain its shape following deformation. The polymer must also be sufficiently resistant to creep to maintain the seal between the plastic cap and the container following radial deformation. It has been found that a polymer having an elongation at yield between 5% and 10% and an elongation at break greater than 100%, combined with a flexural modulus of greater than 1,900 MPa has superior performance. Where the plastic closure of this invention is utilized for sealing vials containing a medicament, the polymer should also be sterilizable and, in certain applications such as the plastic collar for a vial transferset described below, the polymer is preferably relatively clear and maintains its clarity under the stress of deformation or crimping. It has been found that certain polymer alloys or composite polymers including melt blends or alloys and co-polymers having polymers of different malleability and rigidity are preferred in many applications. That is, the plastic closure of this invention is preferably formed of a polymer alloy, composite polymer or co-polymer including a relatively rigid polymer and a tough relatively soft malleable co-polymer. The most preferred polymer is a polymer alloy or melt blend including a polyamide or polycarbonate as the rigid polymer providing the strength and resistance to creep desired for this application. The relatively soft malleable co-polymer may be selected from various polymers including polyesters and polyolefins; however, a polymer alloy including a polycarbonate or polyamide and a polyester has been found particularly suitable for this application.
- As will be understood, various polymeric melt blends, alloys, composites and co-polymers are being developed on a rapidly increasing basis and therefore the plastic collar of this invention is not limited to a specific polymer, provided the polymer has the desired physical properties described above. Suitable polymers for the plastic collar of this invention include EASTAR® MB polymers, which are melt blend and alloy polymers and EASTAR® thermoplastic polymers, which are neat polymers sold by Eastman Chemical Company of Kingsport, Tennessee and Eastman Chemical AG of Zug, Switzerland under the trade names "DA003, DN003" and "DN004". These materials are polymer melt blends, alloys and co-polymers of polycarbonate or polyamide and polyester. As used herein, the terms melt blends and alloys refer to polymeric compositions having two or more polymers of different physical properties or characteristics, such as the EASTAR® polymers of Eastman Chemical Company described above which include a polycarbonate or polyamide and a polyester. The polymer selected for the plastic collar of this invention may also include fillers and other constituents which would be more accurately described as a composite. Although the base polymers may still be a polymeric melt blend or alloy. As used herein, the term composite is used in its broadest sense to include alloys or melt blends, composites and co-polymers. As will be understood, the manufacturer or supplier of the raw material will normally blend the polymers based upon the specifications of the customer. The polymers may be co-injected to form a polymeric melt blend, alloy or composite or formed by any other suitable processes. It is anticipated, however, that other polymers having the described physical characteristics may also be utilized in the plastic collar or cap of this invention. In certain applications, it may also be desirable to coat at least the
interior surface 43 of the collar shown in Figure 2 with a thermoplastic elastomer, or the entire collar may have a thin layer of a thermoplastic elastomer. The thermoplastic elastomer coating may be applied as a film or by co-injection with the polymer forming thecollar 40. Thecollar 40 and theclosure 50 may be formed by conventional injection molding processes. - Although figures 1-3 include an illustration of a generic vial or container for a pharmaceutical substance, this invention is particularly useful for closing off or sealing cartridges that are prefilled with pharmaceutical substances. Such cartridges are well-known and typically are used with injector devices where the cartridge is inserted into the appropriate portion of the injector device by a medical professional prior to administering an injection. The cartridges typically are prefilled with the desired pharmaceutical substance. A variety of cartridge designs are utilized to accommodate substances in different forms.
- Figures 4 and 5 illustrate one example cartridge that includes a
plastic closure 140 designed according to this invention. In this example, thecartridge 122 is utilized within an injector device that is schematically illustrated at 180. Thecartridge 122 includes anopen end 124 that is closed off by anelastomeric stopper member 132 in cooperation with theplastic closure 140. At the opposite end of thecartridge 122, a stopper member 170 operates to maintain a substance within theinterior 131 of thecartridge 122. The stopper member 170 also cooperates with the injector mechanisms schematically illustrated at 160 of theinjector 180 in a conventional manner. - As best seen in Figure 5, the
elastomeric stopper member 132 extends across theopening 124 and includes aportion 136 that rests against therim portion 126 of thecartridge 122. Acentral portion 138 of thestopper member 132 extends across theopening 124 and is piercable by a hypodermic needle device, for example, so that a pharmaceutical substance within thecartridge 122 can be injected in a desired manner. - The
cap 140 has aportion 144 that is crimped or radially deformed inwardly toward the reducedneck portion 128 of thecartridge 122. Theradial portion 146 of thecap 140 effectively maintains thestopper member 132 in place against the end of theshoulder portion 126 of thecartridge 122. - Figures 6 and 7 illustrate another example embodiment where a plastic closure designed according to this invention is provided on the end of a
cartridge 222. In this example, thecartridge 222 includes twostopper members first substance 276 is maintained between thestoppers cartridge 222 is prefilled by a pharmaceutical supplier, for example. Asecond substance 278 is maintained between thestopper 272 and thestopper member 232 at the open end of thecartridge 222. Abypass passage 274 is provided so that when an injector mechanism is used and astopper member 270 is moved toward the end of thecartridge 222 including thestopper member 232, thestopper member 272 proceeds in the same direction and the substance orfluid 276 is permitted to flow through thebypass 274 to mix with thesubstance 278. Those skilled in the art will recognize that this type of cartridge is a especially useful for prefilling cartridges with pharmaceutical substances that are maintained in a dry, powdered or lyophilized form. Thesubstance 276 is typically used for reconstituting thesubstance 278 prior to injecting that substance into a patient. - As best seen in Figure 7, the cap 240 includes the
tubular collar portion 242 and the radially crimped ordeformed portion 244 that both at least partially engage theshoulder portion 226 at the end of thecartridge 222. Thestopper member 232 in this embodiment includes acentral portion 238 and an additional flange portion near theend 236 for engaging the end of thecartridge 222. Otherwise, the operation of the example of Figures 6 and 7 is the same as described above. - Figure 8 illustrates another embodiment where a
plastic cap 340 designed according to this invention is used to close off the end of acartridge 322. In this example, thecartridge 322 includes astopper member 338 at theopen end 324 and a stopper orplunger member 370 at the opposite end. There are twodistinct chambers plunger member 370 and thestopper member 338. Achamber separating portion 384 operates to maintain substances within thechambers plastic cap 340 designed according to this invention provides additional advantages compared to the use of conventional aluminum caps as described above. - Although several example cartridges for maintaining pharmaceutical substances have been illustrated, this invention is not limited to those examples. Any number of cartridge styles or configurations that have a reduced diameter neck portion near the open end, which will accommodate a plastic cap or closure designed according to this invention, can be used as will be appreciated by those skilled in the art who have the benefit of this disclosure.
- As will be understood, various modifications may be made to the disclosed example plastic closures of this invention within the purview of the appended claims. Therefore, the scope of legal protection given to this invention can only be determined by studying the following claims.
Claims (18)
- A plastic closure (40) for sealing a container (22, 122, 222, 322) having an open end (24, 124, 324) and a reduced diameter portion (28, 128, 228, 328) adjacent said open end, said plastic closure comprising a polymer which is sufficiently malleable to permit radial deformation, yet sufficiently rigid to retain its shape following deformation and sufficiently resistant to creep to remain in a desired position on said container following radial deformation,
characterized in that:said polymer has an elongation at yield between 5% and 10%, an elongation at brake greater than 100%, and a flexural modulus of greater than 1,900 MPa. - The plastic closure of Claim 1, wherein said polymer is relatively clear and maintains its clarity under the stress of deformation.
- The plastic closure of Claims 1 or 2, wherein said plastic closure comprises a composite polymer including a relatively soft malleable polymer and a relatively rigid polymer.
- The plastic closure of Claim 3, wherein said plastic closure comprises a polymeric alloy comprising a soft malleable copolymer and said relatively rigid polymer.
- The plastic closure of Claims 3 or 4, wherein said relatively rigid polymer is a polycarbonate or polyamide.
- The plastic closure of Claims 3 or 4, wherein said relatively soft polymer is a polyester or polyolefin.
- The plastic closure of Claim 1, wherein said plastic closure includes an elastomeric coating on an internal surface of a free end of said tubular portion and said elastomeric coating integrally bonded to said internal surface.
- A combination comprising the plastic closure of one of Claims 1-7 and a container, wherein said container (22, 122, 222, 322) includes a radial rim (26, 126, 226, 326) adjacent said open end, said plastic closure having a tubular portion (42, 142, 242, 342) surrounding said container rim and a portion (44, 144, 244, 344) which is permanently deformed radially toward said reduced diameter portion (28, 128, 228, 328) of said container, said tubular portion of said closure including an annular resilient ring retained on an internal surface adjacent said free end preventing rotation of said closure on said container.
- A combination comprising the plastic closure of one of Claims 1-7 and a container, wherein said container includes a radial rim (26, 126, 226, 326) adjacent said open end and an elastomeric stopper (32, 132, 232, 332) extending across said open end of said container and overlying said rim portion of said container, said closure having a tubular portion (42, 142, 242, 342) surrounding said rim portion of said container having a free distal end deformed radially inwardly and engaging said rim portion of said container and an integral proximate radial portion (46, 146, 246, 346) overlying said rim portion of said stopper.
- The combination of Claim 9, wherein said proximate radial portion (46, 146, 246, 346) of said closure includes a central opening (48) overlying a central portion (38) of said stopper and said closure including a cup-shaped cap (50) having a tubular portion (52) overlying a proximate portion of said closure and a radial portion overlying said central opening of said closure and said cap secured to said closure by retainer elements received within said central opening of said closure.
- The combination of Claim 10, wherein said retainer elements are spaced U-shaped tabs integral with said cap received through said central opening of said closure each having a free end engaging a portion of said closure adjacent said central opening.
- The combination of Claim 11, wherein said container is a cartridge adapted to contain a pharmaceutical substance.
- The combination of Claim 12, wherein said cartridge has at least two chambers.
- The combination of Claim 12, wherein said cartridge includes more than one stopper member that selectively move multiple substances within said cartridge.
- The combination of Claim 12, wherein the cartridge has a plurality of chambers.
- The combination of Claim 15, including a plurality of stopper members that move within the cartridge to selectively separate or mix different substances maintained in the plurality of chambers, respectively.
- The combination of Claim 15, including a bypass that permits selective movement of substance from one of the plurality of chambers to another one of the plurality of chambers.
- The combination of Claim 12, including an elastomeric stopper seal member.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42165799A | 1999-10-20 | 1999-10-20 | |
US421657 | 1999-10-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1094012A2 EP1094012A2 (en) | 2001-04-25 |
EP1094012A3 EP1094012A3 (en) | 2002-06-19 |
EP1094012B1 true EP1094012B1 (en) | 2006-12-13 |
Family
ID=23671475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00121655A Expired - Lifetime EP1094012B1 (en) | 1999-10-20 | 2000-10-04 | Plastic closure for vials and other medical containers |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1094012B1 (en) |
JP (1) | JP2001171717A (en) |
AT (1) | ATE348052T1 (en) |
AU (1) | AU774241B2 (en) |
DE (1) | DE60032307T2 (en) |
ES (1) | ES2275466T3 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0129176D0 (en) | 2001-12-06 | 2002-01-23 | Dca Design Int Ltd | Improvements in and realting to a medicament cartridge assembly |
JP4526480B2 (en) * | 2003-06-03 | 2010-08-18 | 大成化工株式会社 | Container cap |
DE102012102881A1 (en) * | 2012-04-03 | 2013-10-10 | Datwyler Pharma Packaging International Nv | Method for producing a crimp cap, crimp cap and container with crimp cap |
EP2826458A1 (en) | 2013-07-17 | 2015-01-21 | F.Hoffmann-La Roche Ag | Closure for a vial |
AT519670B1 (en) * | 2017-06-27 | 2018-09-15 | Greiner Packaging Int Gmbh | Closure arrangement for a packaging container and packaging unit formed therefrom |
WO2020153104A1 (en) * | 2019-01-25 | 2020-07-30 | 株式会社ダイセル | Crack resistant member |
FR3106339B1 (en) * | 2020-01-16 | 2021-12-24 | A Raymond Et Cie | Locking cap for necked container with a cap with separable fastening tabs |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB999159A (en) * | 1961-07-05 | 1965-07-21 | Taylor Pty Ltd Samuel | Improvements in or relating to caps for containers, bottles or the like |
US3278063A (en) * | 1963-02-02 | 1966-10-11 | Faensen Kleinmetall | Sealing device |
US3857579A (en) * | 1973-04-06 | 1974-12-31 | J Hoodenpyle | Cart for moving television, hi-fi cabinets and the like |
JPS5826914Y2 (en) * | 1979-04-20 | 1983-06-10 | 旭硝子株式会社 | ampoule bottle |
US5662230A (en) * | 1990-07-13 | 1997-09-02 | J. G. Finneran Associates | Crimp top seal for vials |
SE9201246D0 (en) * | 1992-04-21 | 1992-04-21 | Kabi Pharmacia Ab | INJECTION CARTRIDGE ARRANGEMENT |
JP3633666B2 (en) * | 1995-05-12 | 2005-03-30 | 大成化工株式会社 | Resin upper lid, resin sealing and tightening unit in which it is appropriately joined to the top surface of the tightening cap, and method for manufacturing the sealing and tightening unit |
WO1997039720A1 (en) * | 1996-04-22 | 1997-10-30 | Abbott Laboratories | Container closure system |
JPH09327500A (en) * | 1996-06-07 | 1997-12-22 | Material Eng Tech Lab Inc | Medicine vessel and transfusion vessel equipped with the same |
US5718348A (en) * | 1996-09-12 | 1998-02-17 | Comar, Inc. | Overcap assembly for gear finish vial |
-
2000
- 2000-10-04 DE DE60032307T patent/DE60032307T2/en not_active Expired - Lifetime
- 2000-10-04 EP EP00121655A patent/EP1094012B1/en not_active Expired - Lifetime
- 2000-10-04 ES ES00121655T patent/ES2275466T3/en not_active Expired - Lifetime
- 2000-10-04 AT AT00121655T patent/ATE348052T1/en not_active IP Right Cessation
- 2000-10-16 AU AU66555/00A patent/AU774241B2/en not_active Expired
- 2000-10-20 JP JP2000321772A patent/JP2001171717A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE60032307D1 (en) | 2007-01-25 |
ATE348052T1 (en) | 2007-01-15 |
AU6655500A (en) | 2001-05-10 |
EP1094012A3 (en) | 2002-06-19 |
EP1094012A2 (en) | 2001-04-25 |
ES2275466T3 (en) | 2007-06-16 |
AU774241B2 (en) | 2004-06-24 |
JP2001171717A (en) | 2001-06-26 |
DE60032307T2 (en) | 2007-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6382442B1 (en) | Plastic closure for vials and other medical containers | |
EP1221923B1 (en) | Transfer set for vials and other medical containers | |
AU782339B2 (en) | Transfer set for vials and medical containers | |
US6681475B2 (en) | Method of sealing a medical container with a plastic closure | |
US6904662B2 (en) | Method of sealing a cartridge or other medical container with a plastic closure | |
EP1094012B1 (en) | Plastic closure for vials and other medical containers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7B 65D 51/00 A, 7B 65D 41/10 B, 7A 61J 1/00 B |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17P | Request for examination filed |
Effective date: 20021113 |
|
AKX | Designation fees paid |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RTI1 | Title (correction) |
Free format text: PLASTIC CLOSURE FOR VIALS AND OTHER MEDICAL CONTAINERS |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BECTON DICKINSON AND COMPANY |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061213 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061213 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061213 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061213 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60032307 Country of ref document: DE Date of ref document: 20070125 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070313 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ISLER & PEDRAZZINI AG |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070514 |
|
ET | Fr: translation filed | ||
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2275466 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: ISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH) |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20070914 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070314 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071004 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071004 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061213 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20190919 Year of fee payment: 20 Ref country code: IT Payment date: 20190918 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20190923 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20190923 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20190918 Year of fee payment: 20 Ref country code: CH Payment date: 20190923 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20191104 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 60032307 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20201003 Ref country code: BE Ref legal event code: MK Effective date: 20201004 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20210128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20201003 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20201005 |